Nanoparticles: An Emerging Hope in Cancer Therapy
Nanomaterials · 24.04.2026 · 16 (9) · 515
DOI: 10.3390/nano16090515 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 24.04.2026. Verfasst von Shahid Sher und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 201 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cancer remains a major global health challenge, characterized by abnormal cell growth and metastasis. Current limitations of conventional therapies, particularly non-specific toxicity harming healthy cells, highlight the need for more targeted approaches. Nanotechnology offers a revolutionary solution, utilizing nanoparticles (NPs) for precise drug delivery to tumor sites while minimizing off-target effects. These nanometer-scale particles enable superior binding to cancer cell membranes, the tumor microenvironment, or nuclear receptors, facilitating significantly higher local concentrations of therapeutic agents. NPs, synthesized via physical, chemical, or biological methods, are categorized as organic (organic material-based) or inorganic (metallic particle-based). Key delivery mechanisms include the Enhanced Permeability and Retention (EPR) effect and Active Transport and Retention (ATR). This review specifically examines NP applications for the most prevalent cancers in the US (2025): breast, prostate, and lung. Gold and magnetic NPs show significant promise for early breast cancer detection. For lung cancer, polymeric NPs like PCL, PLA, and PLGA are effective carriers for peptides, proteins, and nucleic acids. BIND-014, a docetaxel-loaded NP formulation, represents an emerging strategy for prostate cancer. Clinically established examples include liposomal doxorubicin and albumin-bound paclitaxel. We comprehensively discuss the synthesis methods, delivery mechanisms, and the current landscape of NPs in research and clinical trials for these cancers. This analysis underscores the potential of nanotechnology to provide more effective and targeted therapeutic options for cancer patients in the future. A distinctive feature of this review is its comparative cancer-specific analysis of NP platforms in breast, prostate, and lung cancers. Unlike previous generalized reviews, this work integrates synthesis strategies, delivery mechanisms, translational challenges, and clinically relevant formulations to provide a bench-to-bedside perspective on the future of nanomedicine in oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611, USA.
- School of the Environment, Florida Agricultural and Mechanical University, Tallahassee, FL 32307, USA.
- Department of Biological and Environmental Sciences, Faculty of Sciences, Emerson University Multan, Multan 60760, Pakistan.
ORCID-Profile: Shahid Sher, Zaman Khan
Zitieren
APA
Sher, S., Jean, R., & Khan, Z. (2026). Nanoparticles: An Emerging Hope in Cancer Therapy. Nanomaterials, 16(9), 515. https://doi.org/10.3390/nano16090515
Vancouver
Sher S, Jean R, Khan Z. Nanoparticles: An Emerging Hope in Cancer Therapy. Nanomaterials. 2026;16(9):515. doi:10.3390/nano16090515
BibTeX
@article{Sher2026,
author = {Sher, Shahid and Jean, Rosny and Khan, Zaman},
title = {Nanoparticles: An Emerging Hope in Cancer Therapy},
journal = {Nanomaterials},
year = {2026},
volume = {16},
number = {9},
pages = {515},
doi = {10.3390/nano16090515}
}
EUVIMED